Article
Research progress and application prospects of multi-omics integration strategies in precision risk stratification of type 1 diabetes mellitus.
Frontiers in immunology - 1 Jan 2026
Chen Ziyi, Liu Wentao, Guo Zheng, Guo Yuying, Hou Jiaxin, Rong Mengpeng, Zheng Huijuan, Cui Zhaoli
Abstract excerpt
Type 1 diabetes (T1D) is a chronic metabolic disease mediated by autoimmunity. Its pathogenesis involves complex interactions between genetic susceptibility and environmental factors. Conventional T1D risk stratification primarily relies on genetic markers, islet autoantibodies, and glycemic indicators. Although these biomarkers remain indispensable in current clinical practice, they are often insufficient when...
Read the complete abstract on PubMedTopics
- Humans
- Diabetes Mellitus, Type 1
- Multiomics
- Biomarkers
- Risk Assessment
- Precision Medicine
